Low-Dose Decitabine Augments the Activation and Anti-Tumor Immune Response of IFN-γ+ CD4+ T Cells Through Enhancing IκBα Degradation and NF-κB Activation

Xiang Li(Capital Medical University), Jing Nie(Nanfang Hospital)
Frontiers in Cell and Developmental Biology
March 15, 2021
Cited by 14


Related Papers